HLA Typing Kits and Testing CapitalBio

Name: HLA Typing
Brand: CapitalBio Technology Co., Ltd.

The HLA (human leucocyte antigen) system encodes the major histocompatibility complex (MHC) proteins in humans, and is closely related to the body's immune system. The HLA gene complex is located on a 3.6 Mb region within chromosome 6p21. They are the most polymorphic gene family found in the human genome, with more than 10,000 different HLA alleles reported to date, thus the capacity to mount an immune response can be remarkably different between individuals within a cohort selected from a single population.

HLA genes have been strongly implicated in transplant rejection, autoimmune disease, vaccine pharmacogenomics, cancer, and infectious diseases. HLA genotyping is the identification of the HLA class I and class II gene polymorphisms for individuals, which is indispensable for transplant matching and disease association studies.

Capitabio specializes in cutting-edge HLA Typing Kits, designed for the precise human leukocyte antigen test. Our comprehensive solutions cater to both research and clinical applications, ensuring high accuracy in every HLA typing test. Trust Capitabio for reliable and efficient HLA analysis, supporting your scientific and medical endeavors with unparalleled precision.

Inquire Now

HLA Typing Meaning

HLA typing refers to the process of determining the specific alleles present in an individual's human leukocyte antigen (HLA) genes. The HLA system is a group of genes located on chromosome 6 that encode proteins involved in the immune system's recognition and response to foreign substances, such as pathogens or transplanted tissues or organs.

HLA typing is performed through molecular methods, often utilizing techniques like Polymerase Chain Reaction (PCR) and DNA sequencing. These methods analyze specific regions within the HLA genes and identify the alleles present in an individual's genetic makeup.

HLA typing is important for several medical and scientific applications, including organ and tissue transplantation, hematopoietic stem cell transplantation (bone marrow transplantation), predicting disease susceptibility, understanding immune responses, forensic investigations, and population genetics studies.

Matching HLA types between a donor and recipient is crucial in transplantation to minimize the risk of rejection and improve the compatibility of transplanted tissues or organs. In disease research, certain HLA alleles are associated with an increased or decreased risk of developing certain conditions, aiding in understanding genetic factors and designing targeted treatment strategies.

Overall, HLA typing plays a vital role in various fields by providing valuable information about an individual's immune system and genetic compatibility, contributing to personalized medicine and scientific advancements.

HLA Typing Applications

Service	Test content
HLA genotyping	High resolution typing on HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1 sites
KIR genotyping	Before hematopoietic stem cell transplantation, both the donor and patient need to do KIR genotyping
Chimeric STR detection	Detection of cell chimeric rate of donor and patient in patient before and after hematopoietic stem cell transplantation;
Chimeric STR detection	Detection of 23 autosomal STR loci and two sex marker loci
Personalized medication guidance	HLA-B*1502 allele is associated with serious adverse effects of antiepileptic drugs
Personalized medication guidance	HLA-B*5801 allele is associated with severe adverse reactions of ventilation medication
This technique can also be applied in disease susceptibility research, immunology research, population genetics research

CapitalBio HLA Typing Kits

CapitalBio offers HLA typing kits, also known as HLA genotyping kits. These HLA genotyping kits are used in medical laboratories to identify a patient's Human Leukocyte Antigen (HLA) type. HLA molecules play a crucial role in immune response and tissue compatibility. CapitalBio's HLA typing kits likely contain reagents and instructions for extracting DNA, amplifying specific HLA gene regions, and analyzing the genetic variations to determine the patient's unique HLA type. This information is vital for organ transplantation matching, as well as understanding a patient's susceptibility to certain autoimmune diseases.

Business Area of HLA Typing

China Marrow Donor Program
The largest HLA matching laboratory in cooperation with China Marrow Donor Program, as the contractor of sample bank of the China Marrow Donor Program, nearly 2.43 million samples have been stored.
CordBlood Bank
Has reached a long-term and stable strategic partnership with 5 CordBlood Banks across the country, and is the HLA testing(human leukocyte antigen test) laboratory with the most cooperative cord blood banks in China.
Clinical Hospital
The joint HLA matching laboratory of CapitalBio Technology and Peking University Peoples Hospital was formally signed in August 2015. CapitalBio Technology has a strong alliance with domestic authoritative leukemia diagnosis and treatment hospitals, and will jointly build a top international HLA matching center to benefit patients.

Advantages of the HLA Typing

High Resolution and Accuracy: CapitalBio Technology’s HLA typing service provides high resolution and 100% accuracy. This ensures precise results, which are crucial in medical applications such as organ transplantation, gene therapy, and immunological disease and cancer studies.
Flexible Testing Sites: The company offers flexibility in testing sites, including HLA class I (A, B, C) and HLA class II (DQB1, DQA1, DPA1, DPB1, DRB1, DRB3, DRB4, DRB5). This flexibility allows for a comprehensive analysis of the HLA system, providing valuable insights for various applications.
Efficient Sequencing: CapitalBio Technology utilizes capture sequencing, which enables HLA typing in a cost-effective, fast, and high-throughput manner. This efficiency is beneficial in situations where quick results are needed.
Quality Control and Experience: The company maintains strict quality control measures and has rich practical experience in HLA typing. This ensures reliable results and a high level of service.
Sample-to-Report Solution: CapitalBio Technology offers a complete sample-to-report solution, simplifying the process for clients and ensuring a seamless experience.
Wide Application: The HLA typing service provided by CapitalBio Technology has been widely applied in various fields, including organ transplantation, population evolution, gene therapy, as well as immunological disease and cancer studies. This wide application demonstrates the versatility and effectiveness of their HLA typing service.

ASHI (American Society for Histocompatibility and Immunogenetics) Certification

ASHI is the most internationally authoritative institutions in histocompatibility, immunogenetics and transplantation. Obtaining ASHI certification means that CapitalBio's HLA typing testing(human leukocyte antigen testing) capabilities have reached the international advanced level, and it can directly issue clinical trial reports that are acceptable overseas.